Results 161 to 170 of about 3,101,103 (310)
Andrology, EarlyView.Abstract Background Poor semen quality is a well‐known feature in patients with testicular germ cell tumours (GCTs) at the time of diagnosis but the underlying biological reasons are incompletely understood. Objectives This study aimed to identify GCT‐specific clinical factors that are involved with poor semen quality in GCT patients.
Klaus‐Peter Dieckmann +9 more
wiley +1 more source
Increased mortality in patients with non-functioning pituitary tumors: a study in a tertiary center. [PDF]
Front Endocrinol (Lausanne)Vargas-Ortega G +8 more
europepmc +1 more source
Pathologic Characteristics of Somatotroph Pituitary Tumors-An Observational Single-Center Study. [PDF]
Biomedicines, 2023 Tomasik A +7 more
europepmc +1 more source
Pharmacogenetics of follicle‐stimulating hormone action in the male
Andrology, EarlyView.Abstract Male factor infertility (MFI) is involved in half of the cases of couple infertility. The follicle‐stimulating hormone (FSH) therapy is considered efficient to improve semen parameters and pregnancy rate in patients with idiopathic MFI, following the lesson learned from hypogonadotropic hypogonadism.
Andrea Graziani +7 more
wiley +1 more source
Cryptorchidism: Novel genetic insights into CCDC149 mutations
Andrology, EarlyView.Abstract Background Cryptorchidism, characterized by the failure of one or both testes to descend into the scrotum, is a common congenital condition that can lead to infertility and increased risk of testicular cancer. CCDC149, a coiled‐coil domain‐containing protein, has been implicated in various developmental processes, but its role in the male ...
Shengrong Du +8 more
wiley +1 more source
Editorial: Diagnosis and treatment of non-functioning pituitary tumors. [PDF]
Front Endocrinol (Lausanne)Sav A.
europepmc +1 more source
Pituitary Tumors: Molecular Insights, Diagnosis, and Targeted Therapy. [PDF]
Cancers (Basel), 2023 Kageyama K, Nishiyama M.
europepmc +1 more source